SpaceX, Arm among market cap stock movers on Friday
- Investing.com
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Alumis Inc (ALMS)
Track today's live Alumis (ALMS) share price, performance and key data on this page with our current NASDAQ:ALMS stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Alumis share price on the NASDAQ exchange. Use the dropdown to switch exchange for the ALMS share price, head to our technical summary section, which provides analysis on Alumis share price buy/sell indicators using real-time data (or discuss the Alumis (ALMS) stock price today with other investors in the Alumis NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ:ALMS share price (ISIN: US0223071020) to enhance your trading decisions with our free investment tools and resources.
What Is the Alumis Inc Share Price Today?
The Alumis share price today is 24.51.
What Is the Stock Symbol for Alumis Inc
The stock symbol (or 'ticker') for Alumis Inc is "ALMS."
What Stock Exchange Does Alumis Inc Trade On?
Alumis Inc is listed and trades on the NASDAQ stock exchange.
Is Alumis Inc a Good Stock to Buy?
Determining whether Alumis (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current NASDAQ:ALMS share price (ISIN: US0223071020) to enhance your trading decisions with our free investment tools and resources.
What Is the Alumis Inc Share Price Today?
The Alumis share price today is 24.51.
What Is the Stock Symbol for Alumis Inc
The stock symbol (or 'ticker') for Alumis Inc is "ALMS."
What Stock Exchange Does Alumis Inc Trade On?
Alumis Inc is listed and trades on the NASDAQ stock exchange.
Is Alumis Inc a Good Stock to Buy?
Determining whether Alumis (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
23.47
24.96
52 wk Range
2.80
30.60
ALMS is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
23.4724.96
52 wk Range
2.8030.60
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ALMS Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
40.10
Upside
+63.61%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
2 analysts have revised their earnings upwards for the upcoming period
- Alumis receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Alumis receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- SpaceX, Arm among market cap stock movers on Friday
- Investing.com
- Alumis receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
10 Buy
1 Hold
0 Sell
Ratings:
11 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 40.10
(+63.61% Upside)
Earnings
Latest Release
14/05/2026
EPS / Forecast
-0.74 / --
Revenue / Forecast
1.74M / --
Compare ALMS to Peers and Sector
Metrics to compare | ALMS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipALMSPeersSector | |
|---|---|---|---|---|
P/E Ratio | −13.2x | −2.8x | −0.4x | |
PEG Ratio | −0.18 | −0.01 | 0.00 | |
Price/Book | 5.5x | 1.9x | 2.6x | |
Price / LTM Sales | 371.9x | 17.6x | 3.0x | |
Upside (Analyst Target) | 61.2% | 28.8% | 57.3% | |
Fair Value Upside | Unlock | −2.4% | 8.9% | Unlock |
Alumis Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of medicines for autoimmune disorders. The company offers envudeucitinib, a tyrosine kinase 2 (TYK2) inhibitor for the treatment of plaque psoriasis and systemic lupus erythematosus; and A-005, a central nervous system-penetrant allosteric TYK2 inhibitor that is in Phase 1 for the treatment of neuroinflammatory and neurodegenerative diseases. It also develops lonigutamab, a monoclonal antibody targeting IGF-1R for the treatment of thyroid eye diseases; and interferon regulatory factor 5 (IRF5) to address immune dysfunction. The company was formerly known as Esker Therapeutics, Inc. and changed its name to Alumis Inc. in January 2022. Alumis Inc. was incorporated in 2021 and is headquartered in South San Francisco, California.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Alumis (NASDAQ: ALMS) Share Price Today?
The Alumis stock price today is 24.51 USD.
What Stock Exchange Does Alumis (ALMS) Trade On?
Alumis is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Alumis?
The stock symbol (also called a 'ticker') for Alumis is "ALMS."
What Is the Current Alumis Market Capitalisation?
As of today, Alumis (NASDAQ: ALMS) market cap is 3.12B USD.
What Is Alumis's (ALMS) Earnings Per Share (TTM)?
The Alumis EPS is currently -2.31 (Trailing Twelve Months).
When Is the Next Alumis Earnings Date?
Alumis's next earnings report will be released on 19/08/2026.
Is ALMS a Buy or Sell From a Technical Analyst Perspective?
Based on today's Alumis moving averages and other technical indicators, the daily buy/sell signal for ALMS stock is Strong Buy.
How Many Times Has Alumis Stock Split?
Alumis has split 0 times. (See the ALMS stock split history page for full effective split date and price information.)
How Many Employees Does Alumis Have?
Alumis has 226 employees, based on their latest Companies House report.
What is the current trading status of Alumis (NASDAQ: ALMS)?
As of 24/06/2026, Alumis (ALMS) is trading at a share price of 24.51 USD, with a previous close of 24.51 USD. The stock has fluctuated within a day range of 23.47 USD to 24.96 USD, while its 52-week range spans from 2.80 USD to 30.60 USD.
What Is Alumis (ALMS) Price Target According to Analysts?
The average 12-month price target for Alumis is 40.10 USD, with a high estimate of 55 USD and a low estimate of 25 USD. 10 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +63.61% Upside potential.
What Is the ALMS Premarket Price?
ALMS's last pre-market stock price is 24.10 USD. The pre-market share volume is 2,580.00, and the stock has decreased by -0.41, or -1.67%.
What Is the ALMS After Hours Price?
ALMS's last after hours stock price is 24.02 USD, the stock has decreased by -0.49, or -2.00%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.